Robert S. Kass, PhD
The focus of Dr. Kass' research program is on the structure and function of ion channels that are expressed in the heart. Most of the projects in his laboratory focus on understanding functional changes in ion channel activity that are caused by inherited mutations linked to human disease. The laboratory employs a multidisciplinary approach including collaborations with clinical investigators reporting novel mutations; the Department of Chemistry at Columbia, which has contributed novel compounds used to probe mutation-specific pharmacology; and genetically altered mice that enable analysis of the systems consequences of molecular perturbations. The Kass laboratory has trained over 40 post doctoral and 18 pre doctoral fellows. The laboratory is currently funded by multiple NIH awards and has benefited by a modest endowment.
Dr. Kass is a member of the American Heart Association, The Biophysical Society, the American Society for Pharmacology and Experimental Therapeutics, the American Society for Biochemistry and Molecular Biology, and serves as external advisor for several institutions and as Ad Hoc reviewer for the NHLBI. He is a past chair of the National American Heart Association Arrhythmia Study section, and is a Council Member of both The Society of General Physiologists and The Association of Pharmacology Chairs. Dr. Kass is associate editor of the journals Molecular Pharmacology and The Journal of Clinical Investigation.